3月5日 - ** 疫苗制造商 Moderna MRNA.O 股价盘前上涨 9.2% 至 33.19 美元
** 美国证券交易委员会周二晚些时候的文件显示，公司首席执行官Stephane Bancel以每股约31美元的价格买入了约16万股MRNA股票。
** 自 1 月中旬公司将 2025 年销售额预期下调 10 亿美元以来，MRNA 股价已下跌 39.1
** 截至 2 月 14 日，该公司有约 3.85 亿股流通股
** 过去 12 个月股价下跌 68.3
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.